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Background: Guanylate Cyclase C (GC-C) is an apically-oriented transmembrane receptor that is expressed on
epithelial cells of the intestine. Activation of GC-C by the endogenous ligands guanylin or uroguanylin elevates
intracellular cGMP and is implicated in intestinal ion secretion, cell proliferation, apoptosis, intestinal barrier function,
as well as the susceptibility of the intestine to inflammation. Our aim was to determine if GC-C is required for host
defense during infection by the murine enteric pathogen Citrobacter rodentium of the family Enterobacteriacea.
Methods: GC-C+/+ control mice or those having GC-C genetically ablated (GC-C−/−) were administered C. rodentium
by orogastric gavage and analyzed at multiple time points up to post-infection day 20. Commensal bacteria were
characterized in uninfected GC-C+/+ and GC-C−/− mice using 16S rRNA PCR analysis.
Results: GC-C−/− mice had an increase in C. rodentium bacterial load in stool relative to GC-C+/+. C. rodentium
infection strongly decreased guanylin expression in GC-C+/+ mice and, to an even greater degree, in GC-C−/−
animals. Fluorescent tracer studies indicated that mice lacking GC-C, unlike GC-C+/+ animals, had a substantial loss
of intestinal barrier function early in the course of infection. Epithelial cell apoptosis was significantly increased in
GC-C−/− mice following 10 days of infection and this was associated with increased frequency and numbers of C.
rodentium translocation out of the intestine. Infection led to significant liver histopathology in GC-C−/− mice as well
as lymphocyte infiltration and elevated cytokine and chemokine expression. Relative to naïve GC-C+/+ mice, the
commensal microflora load in uninfected GC-C−/− mice was decreased and bacterial composition was imbalanced
and included outgrowth of the Enterobacteriacea family.
Conclusions: This work demonstrates the novel finding that GC-C signaling is an essential component of host
defense during murine enteric infection by reducing bacterial load and preventing systemic dissemination of
attaching/effacing-lesion forming bacterial pathogens such as C. rodentium.
Keywords: Guanylate cyclase, Guanylyl cyclase, cGMP, Intestine, Colon, Attaching and effacing lesion, Epithelial cell
apoptosis, Intestinal barrier functionBackground
Citrobacter rodentium (C. rodentium) are gram-negative
bacteria of the family Enterobacteriaceae, and are natural
enteric pathogens of mice. Related family members, entero-
pathogenic Escherichia coli (EPEC) and enterohemorrhagic
E. coli (EHEC), are human pathogens that are a major cause
of infectious diarrhea worldwide. Similar to these bacteria,* Correspondence: Kris.Steinbrecher@cchmc.org
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reproduction in any medium, provided the orlesion-forming pathogens carry a set of virulence genes
termed the locus of enterocyte effacement which enable
close association with the apical membrane of intestinal
cells, causing local destruction of microvilli and transfer of
effector gene products via a type III secretion system [1].
In C57BL/6 mice and other strains that are considered
resistant to C. rodentium, colonization results in a
self-limiting infection which is cleared by both the innate
and the adaptive immune systems. The course of infection
is characterized by intestinal epithelial cell apoptosis,
infiltration of inflammatory cells, mainly macrophage
and neutrophils, and crypt hyperplasia, all of which are
largely resolved within 3 weeks. In contrast, susceptibletd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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been attributed at least in part to decreased expression
of transporters important in chloride ion homeostasis
[2] and to differences in the intestinal microbiota [3,4].
Guanylate cyclase 2C (encoded by Gucy2c, hereafter
termed GC-C) is a transmembrane receptor present in
the intestine which, in concert with its ligands guanylin
(GN, encoded by Guca2a,) [5] and uroguanylin (UGN,
encoded by Guca2b) [6], is known to regulate both
chloride/bicarbonate ion secretion (via the cystic fibrosis
transmembrane conductance regulator, CFTR) [7,8] and
sodium absorption (via the Na+/H+ exchanger 3, NHE3,
Slc9a3) [9]. The first step in this regulatory cascade is
ligand activation of GC-C to generate the second
messenger cyclic guanosine monophosphate (cGMP).
Some strains of infectious enterotoxigenic E. coli produce
the heat-stable enterotoxin, ST, which acts as a GC-C
superagonist [10]. Unlike activation of GC-C by the
endogenous ligands GN or UGN, robust overproduction
of cGMP by ST-bound GC-C deregulates downstream
signaling pathways and causes secretory diarrhea. Mice
carrying a targeted disruption of Gucy2c have reduced
levels of intestinal cGMP, and are resistant to ST
[11,12]. Importantly, further studies of Gucy2c knockout
(hereafter called GC-C−/−) mice have provided evidence
for actions of GC-C beyond fluid and ion homeostasis
in the gut. Signaling via GC-C has been implicated in
intestinal epithelial cell cycle regulation, apoptosis, and
progression to gastrointestinal cancer [13-15]. More
recently, we have shown the presence of a defective
intestinal epithelial barrier as well as sensitivity to DNA
damage-induced cell death in mice lacking GC-C [16,17].
In a model of chemical-induced intestinal injury, GC-C−/−
mice exhibited a blunted intestinal inflammatory response
that was accompanied by reduced cytokine expression [18].
Based on these findings, we utilized the C. rodentium
model of enteric bacterial pathogen infection to inves-
tigate the hypothesis that GC-C effector pathways are




GC-C−/− mice carrying a targeted deletion of Gucy2c, the
gene encoding GC-C, have previously been described
by us [11]. Heterozygous GC-C+/− mice have been
back-crossed to the C57BL/6 J strain (Jackson Laboratory,
Bar Harbor, Me) for > 10 generations, and GC-C−/− and
GC-C+/+ mouse lines were generated by this process. As
in our recent work [16,18], both GC-C+/+ and GC-C−/−
mouse lines were maintained in the same room of our
animal facility under identical specific-pathogen free
conditions. Mice of both sexes, aged 6–12 weeks were
used, and experiments were performed on age- andgender- matched groups. All studies were approved by the
Cincinnati Children’s Hospital Medical Center Institutional
Animal Care and Use Committee.
C. rodentium infection of mice
C. rodentium bacteria from frozen stocks of strain DBS
100 (gift of Philip M. Sherman, Hospital for Sick Children,
Toronto, Canada) were grown on MacConkey’s agar
(Becton, Dickinson and Company, Sparks, MD) over-
night at 37°C. A single colony was then cultured in
Luria-Bertani broth overnight at 37°C. We used optical
density measurements at 600 nm to assess the concentra-
tion of bacteria, and confirmed colony forming units
(CFU) by plating serial dilutions on MacConkey’s agar.
Within each study, groups of GC-C+/+ and GC-C−/− mice
with free access to food and water were infected by oral
gavage with the same freshly prepared mixture of C.
rodentium (~1.5 × 109 CFU C. rodentium in 100 μl sterile
PBS per mouse). Stool from individual mice was collected
and weighed every few days after gavage, beginning at day
4. To determine bacterial burden, stool was homogenized
in sterile PBS (0.1 g stool/1 ml PBS) and serial dilutions
were plated on MacConkey’s agar. Colonies were counted
after overnight incubation at 37°C. The limit of detection
was 5 × 102 CFU/g stool. A mouse was excluded from
further analysis if the level of C. rodentium was below
the limit of detection at 4 days post-infection. PCR analysis
of the C. rodentium espB gene was performed on represen-
tative colonies to confirm identity.
Analysis of C. rodentium infected mice
Groups of mice were sacrificed at 4, 10, and 20 days
after infection. Colon, feces, and liver were aseptically
removed. A caudal piece (0.5 cm) of the distal colon was
frozen in liquid nitrogen for subsequent RNA extraction,
while the remaining section was split longitudinally into
“swiss rolls” for formalin fixation/paraffin embedding
and for frozen OCT embedding. Sections of liver were
frozen in liquid nitrogen for RNA analysis or fixed in
formalin/paraffin for histology. In addition, liver sections
(trimmed to 0.1 g weight) were homogenized in 1 ml of
sterile PBS, and plated on MacConkey’s agar. C. rodentium
colonies were counted after incubation at 37°C overnight.
The limit of detection for liver homogenates was 40 CFU/g
and identity was confirmed by PCR analysis performed
as above. Tissues from additional naïve (non-infected)
age- and gender-matched mice were similarly obtained
and processed.
Histology, immunofluorescence and immunoblotting
H&E staining of intestinal and hepatic sections was done
using standard techniques as previously described [18,19].
Images were obtained on an Olympus BX51 microscope
equipped with an Olympus DP71 camera and DP Manager
Table 1 Real time RT-PCR primers
Primers Sequences
Gn For 5’- CAC TGT GCA GGA TGG AGA C-3’
Rev 5’-CTC GGC GTT GGG TTT CT-3’
CFTR For 5’-GCA CAG CAG CTC AAA CAA CTG GAA-3’
Rev 5’-TTC TCA TTT GGA ACC AGC GCA AGC-3’
IL-22 For 5’-AAA CTG TTC CGA GGA GTC AGT GCT
Rev 5’-GCT GAG CTG ATT GCT GAG TTT GGT-3’
CXCL9 For 5’-TTT CAT CAC GCC CTT GAG CCT AGT-3’
Rev 5’-TTT GGT GAC GTG AGC CTC AGA AGT-3’
GAPDH For 5’-ACC ACA GTC CAT GCC ATC AC-3’
Rev 5’-TCC ACC ACC CTG TTG CTG TA-3’
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micrographs of all well-oriented crypts from H&E-stained
“swiss roll” sections of distal colon using ImageJ version
1.38 (National Institutes of Health, Bethesda, MD). Stained
slides (distal colon) were also examined to assess colitis
severity in terms of disease scores composed of the degree
of inflammation, hyperplasia, and infiltrate composition
using a modified scoring system based on previous studies
[18,20,21]. Briefly, this system assessed inflammation
(scored 0–4 where 0 is no inflammation and 4 is severe
ulceration and crypt abscess), hyperplasia (0 – 3 where 0
is no hyperplasia and 3 is severe hyperplasia with mucin
depletion), and inflammatory composition (0 – 3 where 0
is none and 3 is substantial mononuclear cells with high
neutrophil content). C. rodentium was localized in the
distal colon by incubating OCT frozen sections with
anti-E. coli Polyvalent 8 LPS antibody (1:500, Denka
Seiken Co., Tokyo, Japan) as according to protocol and
helpful advice from Dr. Bruce Vallance (University of
British Colombia, Canada) [22]. Sections were then in-
cubated with anti-swine CF-488A-conjugated IgG sec-
ondary antibody (1:2000, Sigma-Aldrich Corp., St.
Louis, MO) and counter-stained with DAPI. Apoptosis
was quantitated via immunofluorescence with cleaved
caspase 3 antibody (CC3, antibody #9661, Cell Signaling
Technology, Inc., Danvers, MA) as performed previously
on OCT frozen sections [19,23]. Positive-stained intestinal
epithelial cells were tabulated from 8–12 micrograph
fields (original magnification 200x) per mouse. Immuno-
fluorescence of E-cadherin (#13-1900, Life Technologies;
Carlsbad, CA), claudin 2 (#51-6100, Life Technologies)
and claudin 3 (#341700, Life Technologies) was performed
on frozen sections in a similar manner. Tubulin, claudin 2,
and claudin 3 immunoblotting was performed as previously
described on extracts from homogenized colon.
Real-time RT-PCR
Total RNA was isolated from frozen tissue using Tri
Reagent (Molecular Research Center, Inc., Cincinnati,
OH) according to the manufacturer's protocol. Integrity of
the RNA was verified by visualization of 28S and 18S RNA
after gel electrophoresis. Following cDNA preparation
(starting quantity of 2.5 ug RNA) with random hexamers
(Verso cDNA kit, Thermo Fisher Scientific, Inc., ABgene
House, Epsom, UK), real-time PCR reactions using gene-
specific primers were performed with Brilliant II SYBR
Green QPCR mix (Stratagene, La Jolla, CA) in the
Mx3000p thermocycler (Stratagene). Primer sequences for
GC-C [24], NHE3 [25], and CXCL1 [19] and LBP [26]
have been published previously. Additional primer se-
quences used in this report are given in Table 1. Values
were normalized to expression of glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH), and the average fold
increase relative to the average level in gender-matchednaïve mice was calculated using the comparative threshold
cycle method (ΔΔCt).
Measurement of intestinal permeability
Intestinal permeability was assessed by measuring
movement of a fluorescent tracer (4 kDa FITC-dextran,
Sigma-Aldrich, St. Louis, MO) from the gut lumen to
the blood. Uninfected and day 4 C. rodentium infected
mice of both GC-C+/+ and GC-C−/− genotypes were
orally gavaged with 200ul of 70 mg/ml FITC-dextran
dissolved in water. Mice were given FITC-dextran so-
lution four hours prior to blood collection at sacrifice.
Serum samples were diluted and read in a 96 well plate
at 485 excitation/535 emission along with a FITC-dextran
standard curve. The calculated serum concentration of
FITC-dextran was interpreted as an indication of intes-
tinal permeability.
Bacterial DNA and quantitative PCR analysis
Bacterial DNA was isolated with the QIAamp DNA
Stool Mini Kit (QIAGEN, Valencia, CA) according to
manufacturer’s instructions for pathogen DNA, including
the optional 95°C incubation step. Stool from individual
adult mice was weighed, frozen at −80°C, and homogenized
directly in ASL lysis buffer (QIAGEN) prior to DNA ex-
traction. Genomic DNA from cultures of the laboratory
Escherichia coli strain, DH5α, was also prepared using
this kit. Integrity of DNA was checked by agarose gel
electrophoresis, and the concentration determined using
the Quant-iT dsDNA Broad-Range Assay Kit (Invitrogen,
Molecular Probes, Inc., Eugene, OR). To quantify bacteria,
real-time PCR was performed using Brilliant II SYBR
Green QPCR mix (Stratagene) and published sets of
group- or family-specific 16S ribosomal RNA (rRNA)
gene primers as follows: Eubacterium rectales/Clostridiae
cocoides [27], Enterobacteriacea [27], Atopobium [28]
Lactobacillus [28], Bacteroides-Prevotella-Porphyromonas
[28] and Bifidobacteria [28]. For determining total bacterial
load, universal 16S rRNA gene primers that recognize all
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tions of a known amount of DH5α DNA was generated,
and used to interpolate the quantity of bacteria from each
experimental DNA sample. To assess the relative quantity
of each group the ΔCt method was used with normali-
zation by total bacteria values [29].
Data analysis
Categorical variables were evaluated by Fisher exact test.
Differences in continuous variables were compared using
the Mann–Whitney test or 2-tailed Student t test. For all
analyses, statistical significance was set at P ≤ 0.05 and
was determined using Prism Version 5.03 (GraphPad
Software, Inc., San Diego, CA).
Results
Mice lacking GC-C exhibit increased load of C. rodentium
but retain the ability to clear the infection
Mice were infected with C. rodentium (1.5 × 109 CFU) by
oral gavage. Colonization was monitored by stool culture
beginning at 4 days post-infection (p.i.). The results from
several experiments are summarized in Figure 1A. For both
genotypes the number of C. rodentium CFU recovered
from stool varied widely at 4 days p.i., rose to a plateau
between days 10 and 14, and then declined to the lower
limit of detection by day 20. This is similar to the time
course for infection in C57BL/6 mice previously reported
in the literature [30,31]. There was a strong trend toward
increased C. rodentium load in GC-C−/− mice by 4 days p.i.
but this narrowly missed statistical significance (P = 0.07).
At 10 days p.i., the median number of C. rodentium
present in the stool of GC-C−/− mice was 8 times
higher than GC-C+/+ (GC-C+/+, 7.0 × 106 vs. GC-C−/−,
5.5 × 107 CFU/g stool, P ≤ 0.02). This was not the case
during the latter stages of the infection course when
adaptive immunity typically reduces C. rodentium numbers
and eventually clears the pathogen. We used immuno-
fluoresent staining with antibodies reactive to C. rodentium
lipopolysaccharide (LPS) to localize the bacteria in distal
colon tissue sections at days 4 (data not shown) and 10 p.i.
(Figure 1B). At both time points, there was no difference in
localization of the pathogen as there was apparent staining
at the epithelial cell surface of both genotypes. There were
also occasional crypts that exhibited staining along the
upper crypt epithelium in both genotypes.
Mice of the C57BL/6 J genetic background do not
respond to C. rodentium infection with grossly obvious
clinical symptoms such as weight loss or diarrhea [2,32].
As expected, we found this to be the case in GC-C+/+
mice and, in fact, there were no symptoms of diarrhea or
loss of body weight in GC-C−/− mice as well (data not
shown). Real-time RT- PCR analysis showed that the level
of GC-C expression in the distal colon of GC-C+/+ mice
was modestly elevated at 10 p.i. (Figure 2). Production ofGN, the most abundant colonic ligand of GC-C, was sub-
stantially decreased beginning at day 4 of infection in both
genotypes, although this was significantly greater in
infected GC-C−/− mice relative to infected wildtype ani-
mals. It was notable that loss of Gn expression begins at
infection day 4, prior to the pronounced epithelial
hyperplasia or goblet cell loss typically seen by us and
others in C. rodentium infected mice at later disease time
points. GC-C generates cGMP that in turn controls the
activity of several epithelial ion transporters, many of
which are transcriptionally regulated during C. rodentium
infection [32,33]. CFTR chloride channel mRNA increased
at day 10 p.i. in mice of both genotypes compared to unin-
fected mice while there was no difference in expression of
the Na+/H+ exchanger NHE3 (Figure 2).
Epithelial hyperplasia during C. rodentium infection is not
affected by deletion of GC-C−/−
Bacterial pathogen infection of the colon is often associated
with a derangement in epithelial homeostasis as reflected
by altered crypt architecture and cell death. For example,
crypt hyperplasia is a hallmark of the host response to cell
death and inflammation caused by C. rodentium infection
[34]. Histological examination of C. rodentium infected
mice at day 10 p.i. revealed significant epithelial hyperplasia
in both GC-C+/+ and GC-C−/− mice (Figure 3A). Marked
inflammation and immune cell infiltrate were also appar-
ent in both genotypes and was not affected by the absence
of GC-C (histologic disease score for GC-C+/+, 5.2 ± 0.8 vs.
GC-C−/−, 6.0 ± 0.7, mean with SE, n = 12 mice per group,
P = 0.49, Student t test). Depth measurements were taken
in well-oriented crypt sections from the distal colon of
naive and day 10 infected mice (Figure 3B). A modest
but significant increase in crypt depth was found in naive
GC-C−/− distal colon compared to wild type (164 ± 1.67 μm
vs. 146 ± 1.92 μm, mean ± SEM, P ≤ 0.0001). This is in
agreement with earlier studies by us and others showing
increased crypt depth in the colon of mice lacking GC-C
or GC-C-activating ligands such as GN [35,13]. C.
rodentium infection significantly increased crypt depth in
both genotypes as measured at day 10 p.i. However, no
significant difference in colonic crypt depth between
infected GC-C+/+ (219 ± 2.09 μm) and infected GC-C−/−
(216 ± 1.61 μm) mice was detected.
GC-C regulates colonic epithelial apoptosis during
bacterial pathogen infection
We have previously shown that GC-C activity plays an
important role in regulating epithelial apoptosis during
radiation and chemical challenge [17,18]. C. rodentium
infection is associated with increased epithelial cell death
in the intestine [1]. Therefore, we quantitated staining
of epithelial cleaved caspase 3 as a marker of apoptosis
in colonic sections from naïve, day 4, and day 10
AB GC-C+/+ GC-C-/-
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Figure 1 GC-C−/− mice have an increased load of C. rodentium compared to GC-C+/+ but are still able to clear the infection. A: Increasing
numbers of C. rodentium were detected in stool from GC-C−/− mice such that by day 10 there were significantly greater numbers of C. rodentium
present relative to GC-C+/+. Note that both genotypes were able to clear the infection by day 20. Each time point consisted of groups of 3–26
mice. Solid line represents median value. Dotted line indicates limit of detection (500 CFU/g stool). Samples below limit of detection were
arbitrarily given a value of 100. B: Representative photomicrographs of sections of distal colon of infected GC-C−/− and GC-C+/+ mice labeled with
LPS specific antibody (green) exhibit similar bacterial localization at day 10 p.i. Images were counterstained with DAPI (blue). Original
magnification was 400X.
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level of cell death in naïve GC-C+/+ and GC-C−/− colon
(Figure 4A). While there was only a minimal increase
in C. rodentium infected mice of either genotype at day
4 p.i., cleaved caspase 3 staining was highly elevated at
day 10 p.i. in GC-C−/− mice as compared to wildtype
controls. Notably, widespread and pervasive epithelial cell
death in GC-C−/− colon was apparent. Quantitation of
cleaved caspase 3-positive epithelial cells demonstrated
nearly a doubling of apoptosis in GC-C−/− mice relative
to GC-C+/+ animals at day 10 p.i. (Figure 4B). These data
clearly indicate that GC-C is essential for epithelial cell
resistance to cell death induced by attaching and effacing
lesion forming bacteria.Citrobacter infection induces barrier dysfunction
in the absence of GC-C
In the context of C. rodentium infection, increased hyper-
plasia and cell death at the height of infection (~day 10
p.i.), such as that measured in GC-C+/+ and GC-C−/− mice,
can enhance epithelial permeability. Previous work by
us and others indicates that GC-C may be important in
regulating intestinal barrier function as its deletion corre-
lates with loss of epithelial tight junction stability in the
bowel [16,36]. Therefore, we hypothesized that subtle
defects in colonic barrier function may be apparent in
GC-C−/− mice early in the course of C. rodentium infection,
prior to the widespread epithelial damage present by day
10 p.i. In order to track potential movement of luminal








































































Figure 2 Differential expression of GC-C, GN, and ion transport genes in the distal colon of naïve and infected mice. While GC-C
expression was slightly increased at 10 p.i., GN was substantially decreased in GC-C+/+ mice and to an even greater degree in GC-C−/− animals at
both day 4 and day 10 p.i. In both genotypes, CFTR expression was elevated while NHE3 was unchanged. Fold change values are relative to
naive GC-C+/+ gut. Solid line represents median value. (**P ≤ 0.007; #P≤ 0.02 naïve vs. infected of the same genotype; n = 6-13 mice per group;
D4, day 4 p.i.; D10, day 10 p.i.)
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serosal compartment, we orally gavaged uninfected
and day 4 p.i. GC-C+/+ and GC-C−/− mice with a 4 kDa
fluorescent tracer (FITC-dextran) four hours prior to
necropsy. Unlike GC-C+/+ mice, animals lacking GC-C
had a substantial loss of barrier function following 4 days
of C. rodentium infection as indicated by increased serum
FITC fluorescence relative to infected GC-C+/+ mice
(Figure 5A). Claudin proteins are essential for tight junction
stability and loss of specific claudin isoforms is associated
with barrier dysfunction during C. rodentium infection
[16,36-38]. Therefore, we selected two relevant claudin
proteins, claudins 2 and 3, and determined their
localization and expression levels in C. rodentium-infected
wildtype and GC-C−/− mice at day 4 p.i. Colonic sections
(Figure 5B), counter-stained with E-cadherin and DAPI,
showed no genotype-dependent differences in cell mem-
brane localization of either claudin 2 or claudin 3. Further-
more, immunoblotting demonstrated that each was present
in similar quantities within the colon of GC-C+/+ and
GC-C−/− mice (Figure 5C). Collectively, these data demon-
strate that GC-C is essential for preserving colonic barrier
function beginning at the earliest stages of enteric bacterial
infection but that additional studies will be necessary todefine the molecular mechanisms that drive this loss of
function in GC-C−/− mice.
GC-C limits systemic dissemination of C. rodentium
A low level of bacterial translocation from the intestine
to the blood, liver, and other organs occurs during the
course of experimental C. rodentium infection [39,40]. The
barrier dysfunction and increased apoptosis found in
GC-C−/− mice during infection suggested that these
mice may fail to sequester the pathogen in the intestine.
We therefore assessed C. rodentium translocation out of
the intestine by plating liver homogenates from colonized
mice on MacConkey’s agar. At 4 days p.i., no live bacteria
were detected in homogenized liver from either genotype.
However, by day 10 p.i. there were significantly more
GC-C−/− mice that exhibited colony growth: 31% (4/13)
of GC-C+/+ livers were positive for C. rodentium compared
to 88% (14/16) of GC-C−/− livers (P ≤ 0.003, Fisher’s exact
test). The number of colony forming units of C. rodentium
recovered from day 10 p.i. liver samples was also signifi-
cantly increased in mice lacking GC-C (Figure 6A). By
day 20, colonies were no longer detectable from livers of
GC-C−/− mice, consistent with the time course of bacterial


























Figure 3 Colonocyte hyperplasia is increased in response to
infection to a similar extent in both GC-C+/+ and GC-C−/− mice.
A: Analysis of distal colon of naïve and day 10 p.i. mice revealed that
there was no substantial difference in histopathology or epithelial
cell hyperplasia in GC-C+/+ and GC-C−/− mice. Scale bars = 100 μm,
original magnification 400X. B: Quantitative analysis revealed a
significant difference in crypt depth in the distal colon of uninfected
GC-C−/− mice compared to GC-C+/+ mice (n = 4 per group with a
minimum of 30 crypts counted per mouse). In response to infection,
the distal colons of both GC-C+/+ mice and GC-C−/− mice show a
significant increase in crypt depth (n = 12 per group with a
minimum of 16 crypts per mouse). Data is presented as the mean




























Figure 4 C. rodentium infection elicits colonocyte apoptosis to
a greater degree in GC-C−/− mice than in GC-C+/+. A:
Immunofluorescent detection of the apoptotic marker cleaved caspase
3 (CC3) in representative sections of distal colon. Elevated numbers of
positively stained epithelial cells are visible in sections from mice at
days 4 and 10 following infection compared to naïve mice, with the
highest staining seen in GC-C−/− gut at day 10 p.i. Scale bars = 200 μm.
B: A significant increase in the mean number of CC3-positive intestinal
epithelial cells (CC3+ IEC) per high power field (HPF) was found in day
10 p.i. distal colon of GC-C−/− compared to GC-C+/+ mice. Data is
presented as the mean with SE. (*P≤ 0.0001; Student t test; #P≤
0.0001 naïve vs. day 10 p.i.; naïve and day 4 mice n = 4 per group; day
10 mice n = 12 per group; D4, day 4 p.i.; D10, day 10 p.i.).
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from wildtype and GC-C−/− mice. Day 4 p.i. liver histology
revealed mild inflammatory infiltrate with no indication
of increased severity in GC-C−/− mice as compared to
GC-C+/+ animals (data not shown). Consistent with a lack
of intestinal containment of C. rodentium, focal areas of
necrosis at day 10 p.i., were noted in the liver of GC-C−/−
mice upon necropsy whereas none could be seen in the
livers of any mice of the GC-C+/+ group (Figure 6B).
This damage was apparent histologically as well, and
included multiple areas of inflammatory infiltrate visible
upon microscopic examination of GC-C−/− liver sections
(Figure 6C).
Our analysis then focused on gene expression in livers
of mice infected with C. rodentium with the expectation
that inflammation in GC-C−/− mice would coincide withelevated activation of pro-inflammatory genes. Relative to
naïve mice, we found that there was increased liver ex-
pression of inflammatory cytokines and chemo-attractants
such as IL-22, CXCL1, and CXCL9 and that this increase
was significantly more in mice lacking GC-C (Figure 7).
Similarly, lipopolysaccharide binding protein (LBP)
was elevated at day 4 p.i. in GC-C−/− liver. These data
are consistent with initial barrier dysfunction occurring at
day 4 p.i. and suggests that intestinal barrier loss and
circulation of luminal contents precedes translocation of




































Figure 5 GC-C is essential to maintain intestinal barrier function
during C. rodentium infection. A: GC-C+/+ and GC-C−/− mice were
given a FITC-dextran tracer by oral gavage on day 4 p.i. and serum
fluorescence was measured four hours later. Relative to naïve mice as
well as infected GC-C+/+ animals, GC-C−/− mice have a substantial and
significant increase in tracer movement from the gut lumen into the
blood indicating a loss of intestinal barrier function. (*P≤ 0.05;
n = 4 – 8 mice per group). B: Immunofluorescent staining of claudin 2
or claudin 3 (green) with E-cadherin (red) and DAPI (blue) counter stains
reveals no apparent differences between infected control and GC-C−/−
mice at day 4 p.i. C: Immunoblotting of claudin 2 and claudin 3 shows
similar protein levels in extracts from distal colon of mice infected by C.
























Figure 6 Dissemination of C. rodentium from the intestine
causes liver injury in GC-C−/− mice at day 10 following
infection. A: In colonized mice, GC-C−/− livers had significantly more
C. rodentium CFU/g as compared to GC-C+/+ livers. (*P≤ 0.003). B:
Gross areas of necrosis were apparent in the livers of some GC-C−/−
mice at necropsy while none were seen in GC-C+/+ livers. C:
Representative photomicrographs illustrate the presence of
lymphocyte aggregates (black arrows) and areas of hemorrhage
visible only in GC-C−/− mice (original magnification 200x).
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naïve mice lacking GC-C
Commensal microflora load and diversity are strongly
influenced by epithelial ion transport in the intestine[41-44]. Importantly, the pathogenicity of C. rodentium
is affected by the complement of commensal bacteria in
the gut [3,4]. We therefore used bacterial DNA extracted
from stool to monitor any potential differences in bacterial
load or composition in naive GC-C−/− mice compared
to GC-C+/+. Bacterial load was quantified by PCR with
universal primers that recognize eubacterial 16S ribosomal
RNA genes, and then normalized to stool weight. We
initially found a statistically significant decrease in stool
bacterial load in GC-C−/− mice (GC-C+/+ , 2.3 × 107
copies/gram stool vs. GC-C−/−, 1.0 × 107, n = 10–12,
P ≤ 0.002, Mann Whitney test). We next utilized group
and family-specific 16S gene primers to assess microflora
diversity from GC-C+/+ stool compared to GC-C−/− stool
(Figure 8). In stool from GC-C−/− mice there was in-
creased levels of Enterobacteriacae (1.0 vs. 3.1 fold-change,
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Figure 7 Pro-inflammatory gene expression is enhanced in GC-C−/− livers at 4 and 10 days post-infection. Real time RT-PCR was used to
assess differences in liver gene expression from naive and infected mice at days 4 and 10 p.i. At day 4, levels of CXCL1, CXCL9, and LBP were
increased in liver from GC-C−/− mice. Consistent with the obvious liver damage seen in the GC-C−/− mice at day 10, levels of IL-22, CXCL1, and
CXCL9 were significantly elevated. All values are relative to the level in uninfected GC-C+/+ liver. Line represents median value. (**P ≤ 0.005, *P ≤
0.05, n = 4-10 mice per group; D4, day 4 p.i.; D10, day 10 p.i.).
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group (1.0 vs. 0.23 fold-change, P ≤ 0.01) compared to
GC-C+/+ mice. No differences were found with primers
recognizing Bifidobacteria, Eubacterium rectale/Clostridiae
cocoides, and the Bacteroides-Prevotella-Porphyromonas
group.
Discussion
Targeting of GC-C by ST results in severe secretory
diarrhea and is a significant cause of morbidity and
mortality in children of developing countries. It has long
been speculated that this GC-C-conferred susceptibility
to some forms of enteric infection is offset by a critical
role for this receptor in intestinal homeostasis. We andothers have suggested that GC-C is important for epithelial
ion transport, cell proliferation, and barrier function and
that GC-C modulates intestinal disorders ranging from
cystic fibrosis to gastrointestinal cancer to intestinal injury
and inflammation via these effects [14,16-18,45]. Here, we
extend the role of GC-C in the intestine by demonstrating
that, although it is exploited by ST-producing ETEC, this
pathway is highly protective during enteric infection by
attaching/effacing bacterial pathogens which do not
produce ST toxin. Specifically, we show that GC-C is
required to minimize bacterial load during the early to
middle phases of C. rodentium infection. We also dem-
onstrate that GC-C activity is essential for maintaining
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Figure 8 The composition of commensal bacteria is altered in naive GC-C−/− mice relative to GC-C+/+. Real time PCR of bacterial genomic
DNA extracted from stool was performed using family-specific bacterial 16S rRNA gene primers. There was significant enrichment of
Enterobacteriaceae and Atopobium in GC-C−/− compared to GC-C+/+ while the level of Lactobacillus was decreased. Line represents median value.
(Entero., Enterobacteriaceae; Lacto., Lactobacillus; Bifido., Bifidobacteria; E. rectale, Eubacterium rectale; C. cocoides, Clostridiae cocoides; WT, wildtype
GC-C+/+; KO, GC-C−/−; *P < 0.03, ** P < 0.005, n = 10–12 per group).
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suppressing epithelial apoptosis at later time points.
The important role of GC-C in controlling pathogen
load and intestinal barrier function is likely instrumental
in minimizing systemic dissemination of attaching/
effacing lesion forming bacteria such as C. rodentium. Fur-
thermore, we demonstrate several additional novel aspects
of epithelial GC-C/cGMP signaling. First, in the context of
the C57BL/6 genetic background, infection by attaching/ef-
facing bacteria such as C. rodentium does not significantly
disrupt intestinal fluid homeostasis in the absence of GC-C.
Second, loss of GC-C has no apparent impact on the
hyperplasia of epithelial crypts that occurs in response
to infection by attaching/effacing bacterial pathogens.
Third, Gn expression is profoundly reduced during C.
rodentium infection and this occurs prior to epithelial
hypertrophy or substantial immune cell infiltration. Fourth,
GC-C regulates the number and composition of intestinal
commensal microflora in naïve mice.
Several multifunctional effector proteins (such as EspF
and Map) common to C. rodentium and other attaching/ef-
facing pathogens, cause host epithelial cell apoptosis as well
as the disruption of intercellular tight junctions [37,46,47].
Bacterial translocation is associated with the intestinal cell
death, inflammation, and barrier dysfunction seen during
experimental C. rodentium infection [31,39,48]. We have
previously reported increased radiation-induced intestinalepithelial cell apoptosis and epithelial barrier dysfunction
in response to LPS challenge that resulted in translocation
of commensal bacteria in GC-C−/− mice [16,17]. In the
current study, we show both a loss of barrier integrity in
the intestine at early stages of infection and a significant
elevation in intestinal epithelial apoptosis in GC-C−/− mice
that culminates in translocation of C. rodentium out of the
intestine. While this correlates with the increased bacterial
load in stool from GC-C−/− at day 10, it is notable that we
did not find major differences in the localization of C.
rodentium colonization within the colon of GC-C−/− mice
as compared to GC-C+/+. At day 4, prior to translocation
of live bacteria, there was significantly increased intestinal
permeability in GC-C−/− mice and this correlated with
elevated expression of chemokine and acute phase genes
in the liver as compared to GC-C+/+. Collectively, this
work indicates that GC-C activity is an essential component
of epithelial barrier function and anti-apoptosis and is re-
quired for multiple aspects of intestinal barrier function
during enteric infection.
There is increasing evidence that complex, reciprocal
crosstalk between the host and its commensal microflora
has a broad and profound impact on gastrointestinal
mucosal immunity and is a critical factor in defining
susceptibility to cancer, inflammation, obesity as well as
infection by bacterial pathogens [49]. Fecal transplant from
a C. rodentium-resistant mouse strain reduced mortality in
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treatment with the probiotic bacteria Lactobaccillus
promoted survival of C. rodentium-infected neonatal
mice [50], while exposure to a stressor (physical restraint)
both altered gut microbial composition and increased
colonization by C. rodentium [51]. Many factors shape
the influence of commensal microflora on colonization
resistance to a pathogen, and may include direct inhibition
by bacteriocins (antimicrobials generated by bacteria),
bacterial metabolites, or competition for nutrients [49].
Alternatively, the abundance of closely related family
members may be indicative of the potential success of a
pathogen from the same family with related growth
characteristics [52]. Because an imbalance in intestinal
microflora often occurs in mice with deregulated ion
transport pathways [41,43], we investigated whether this
may contribute to the increased C. rodentium colonization
noted in GC-C−/− mice. Here, we have demonstrated that
loss of GC-C has a significant impact on the abundance
and systemic dissemination of an enteric bacterial pathogen
and we further show that naïve GC-C−/− mice have a
significant imbalance in intestinal bacterial species relative
to their GC-C+/+ counterparts. In addition to a decrease in
potentially protective Lactobacillus, the Enterobacteriaceae
family colonizes the gut of naïve GC-C−/− mice at higher
levels than GC-C+/+, as does the Enterobacteriaceae family
member C. rodentium during the early stages of the infec-
tion course. It is possible that GC-C activity regulates out-
growth of commensal bacteria as well as C. rodentium by
affecting epithelial mucus layer dynamics, cell surface
or luminal pH, or the ion/solute-dependent aspects of
bacterial metabolism and growth. Additional studies
will be necessary to define the mechanism through which
GC-C influences the composition and load of commensal
bacteria.
External factors, such as variation in diet and animal
husbandry conditions at any given research institute,
impact the composition of gut microflora and can have
a dominant influence on disease model phenotype [53-55].
Therefore, genetically-modified mice used as models of
gastrointestinal pathology such as bacterial infection,
inflammation, obesity, and tumor susceptibility reflect
the interaction between investigator-imposed genetic
modifications and institution- or animal colony-dependent
microflora. Further characterization and study of the
microbiome of the GC-C−/− intestine will be necessary
to establish its specific role in susceptibility to bacterial
infection as well as its putative broader impact on
gastrointestinal pathophysiology.
Conclusions
In summary, we have identified a protective role for GC-C
signaling in defense against an attaching/effacing lesion-
forming bacterial pathogen. Our studies have shown thatGC-C is required to maintain an effective epithelial barrier
and to suppress systemic dissemination of C. rodentium.
We also demonstrate an imbalance in commensal micro-
flora in naïve GC-C−/− mice relative to GC-C+/+ animals
from the same colony and speculate that this is an import-
ant component in the increased colonization of enteric
pathogens in mice lacking GC-C.
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